A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer
A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer
Active, not recruiting · NCT06584435 · Registry updated 2025-12-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer | High-risk Renal Cell Carcinoma | Active, not recruiting | Phase 2 | 2025-12-19 | NCT06584435 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Second Hospital | 50 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Changyi Quan | Tianjin | China | 2 |